期刊文献+

透皮贴剂制品及研究进展 被引量:12

下载PDF
导出
摘要 近年来,透皮给药系统(TDDS)作为一类特殊的给药途径,以其独特的优势吸引着国内外越来越多的药剂学工作者的目光,这方面的研究报道逐年递增。经过不断的科学研究,已取得了不少成果。至今已有许多透皮制剂获准上市,还有部分已进入临床研究。本文试对透皮制剂中已上市的和研究中的热点药物做一简单分类介绍,供同仁参考。
出处 《药学实践杂志》 CAS 2010年第3期161-163,188,共4页 Journal of Pharmaceutical Practice
  • 相关文献

参考文献30

  • 1Barry BW. Is transdermal drug delivery research still important today? [J]. Editorial DDT, 2001, 6( 19 ) : 967.
  • 2Wang FJ, Yang YY, Zhang XZ, et al. Cellulose acetate membranes for transdermal delivery of scopolamine base [J]. Mater. Sci. Eng. C, 2002, 20(1-2) : 93.
  • 3Galer BS, Rowbotham MC, Perander J, et al. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study [ J ]. Pain, 1999, 80(3) : 533.
  • 4黄胜炎.主动透皮释药技术进展[J].上海医药,2006,27(12):544-546. 被引量:1
  • 5Pae CU, Lira HK, Han C, et al. Selegiline transdermal system.. Current awareness and promise [ J]. Progress in Neuro-Psychopharmacology & Biological Psychiatry ,2007, 31 : 1153.
  • 6Pham DQ, Nogid A. Rotigotine transdermal system for the treatment of parkinson' s disease [ J]. Clinical Therapeutics, 2008, 30(5) : 813.
  • 7Lefevre G, Sedek G, Jhee S, et al. Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimerg disease patients [J]. Clila. Pharmacol . Ther. 2008, 83 : 106.
  • 8Winblad B, Cummings J, Andreasen N, et al. A six-month, double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer 's disease-rivastigmine patch versus capsule[ J]. Int J Geriatr Psychatryi, 2007, 22 (5) : 456.
  • 9全球医药快讯FDA连线.世界临床药物,2008,29(10):636-636.
  • 10Minville V, Lubrano V, Bounes V,et al. Postoperative analgesia after total hip arthroplasty: patient-controlled analgesia versus transdermal fentanyl patch[J]. J. Clin. Anesth. 2008, 20(4) : 280.

二级参考文献4

  • 1[1]Jarrot B,Comway EL,Maccarone C,et al.Clonidine:understanding disposition,sites and mechanism of action[J].Clin Exp Pharmacol,1987,14(3):471-479.
  • 2[2]Weber MA,Drayer JM.Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal system[J].Clin Auton Res,1993,3(2):391-396.
  • 3[3]Burris JF.The USA experience with the clonidine transdermal the rapeutic system[J].Clin Auton Res,1993,3(2):397-399.
  • 4[5]Shaw JE.Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route[J].Am Heart J,1984,108(1):217-222.

共引文献11

同被引文献123

引证文献12

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部